Literature DB >> 8392005

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator.

C Pyke1, J Eriksen, H Solberg, B S Nielsen, P Kristensen, L R Lund, K Danø.   

Abstract

Using 3' RACE (rapid amplification of cDNA ends), we have isolated a cDNA variant for the receptor for human urokinase plasminogen activator (uPAR). The deduced protein includes the amino-terminal ligand binding domain in uPAR, but lacks the carboxy-terminal membrane attachment by a glycolipid anchor. Genomic DNA analysis showed that the uPAR mRNA variant is generated by alternative splicing. The new variant mRNA is expressed in various human cell lines and tissues and both variants are up-regulated by phorbol ester in A549 cells. We propose that the alternatively spliced uPAR mRNA encodes a soluble uPA binding protein, the possible function of which is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392005     DOI: 10.1016/0014-5793(93)81763-p

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Functional convergence of signalling by GPI-anchored and anchorless forms of a salamander protein implicated in limb regeneration.

Authors:  Robert A Blassberg; Acely Garza-Garcia; Azara Janmohamed; Phillip B Gates; Jeremy P Brockes
Journal:  J Cell Sci       Date:  2010-11-30       Impact factor: 5.285

2.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

3.  Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function.

Authors:  Ceri E Stewart; Ian Sayers
Journal:  Lung       Date:  2013-02-14       Impact factor: 2.584

4.  beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.

Authors:  S Hapke; M Gawaz; K Dehne; J Köhler; J F Marshall; H Graeff; M Schmitt; U Reuning; E Lengyel
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.

Authors:  Changli Wei; Jing Li; Brian D Adair; Ke Zhu; Jian Cai; Michael Merchant; Beata Samelko; Zhongji Liao; Kwi Hye Koh; Nicholas J Tardi; Ranadheer R Dande; Shuangxin Liu; Jianchao Ma; Salvatore Dibartolo; Stefan Hägele; Vasil Peev; Salim S Hayek; David J Cimbaluk; Melissa Tracy; Jon Klein; Sanja Sever; Sanford J Shattil; M Amin Arnaout; Jochen Reiser
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

Review 6.  Soluble Urokinase Receptor and Liver Disease.

Authors:  Changli Wei; Ke Zhu; Jochen Reiser
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-12-20

7.  Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.

Authors:  Boris K Pliyev; Mikhail Yu Menshikov
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

8.  The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

Authors:  C Pyke; J Rømer; P Kallunki; L R Lund; E Ralfkiaer; K Danø; K Tryggvason
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

9.  Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).

Authors:  Boris K Pliyev
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.396

10.  Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.

Authors:  Ceri E Stewart; Ian Sayers
Journal:  BMC Mol Biol       Date:  2009-07-28       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.